|
|
|
Volumn 12, Issue 11 A, 1998, Pages 37-49
|
|
Roundtable discussion. Investigational exclusion, clinical trials, and cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
CLINICAL TRIAL;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEALTH CARE DELIVERY;
HUMAN;
INFORMED CONSENT;
LEGAL ASPECT;
METHODOLOGY;
NEOPLASM;
PATIENT SELECTION;
PEER REVIEW;
REIMBURSEMENT;
RISK MANAGEMENT;
STANDARD;
UNITED STATES;
CLINICAL TRIALS;
FINANCIAL SUPPORT;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INFORMED CONSENT;
INSURANCE, HEALTH, REIMBURSEMENT;
NEOPLASMS;
PATIENT SELECTION;
PEER REVIEW, RESEARCH;
RISK MANAGEMENT;
UNITED STATES;
|
|
EID: 0032196188
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
